- NBR - The National Bureau of Asian Research

Asia’s Evolving Life Science Sector

Health Project Leadership

Claire Topal
Senior Advisor, International Health

Benjamin Shobert
Senior Associate, International Health

Current Research:

The Globalization of China’s Life Science Sector

Our China-focused research examines Chinese government support for its life sciences sector and the implications for international scientific competition and innovation, as well as its broader impact on U.S.-China political and economic relations.

We provide analysis of numerous Chinese government actions and policies that represent a departure from international trade norms, as well as the ability of the country’s policies to be as disruptive to global life science R&D and drug commercialization as they have been for clean-tech. Learn more.

Leveraging New Investments in Japan’s Life Science Sector for Renewed Economic Growth

Our Japan-focused research examines Japan’s ability to leverage the life sciences as a key driver of economic growth. We explore the implications of new reforms on domestic collaboration and innovation. We also provide analysis on competition within the Asia-Pacific region from countries with similar objectives but more mercantilist approaches.


Claire Topal
Senior Advisor, International Health

Sino-U.S. Relations Through a Life Sciences Prism

Yanzhong Huang (Council on Foreign Relations) analyzes China's policies toward its life sciences sector and considers their impact on political and economic relations with other Asian countries and the United States.

Benjamin Shobert Testifies before the U.S.-China Economic and Security Review Commission

On April 3, 2014, Benjamin Shobert testified before the U.S.-China Economic and Security Review Commission at the hearing on "China's Healthcare Sector, Drug Safety, and the U.S.-China Trade in Medical Products." Read his prepared remarks and view the video.